ReviewSurgery open science2025
The succession of One Day Surgery with Breast Cancer Home Recovery Program by the National Cancer Institute (ODS BHR NCI) during the COVID-19 pandemic in Thailand.
Review in Surgery open science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer is the most common cancer among women. In response to the need to hospital stays and minimize waiting time for surgery, particularly during the COVID-19 pandemic, the National Cancer Institute developed the One Day Surgery with Breast cancer Home Recovery program (ODS BHR NCI). The aim of study is to assess the success rate of breast cancer surgeries conducted through this program and to evaluate the incidence of complications. Method: The cohort study includes all breast cancer patients who underwent surgery through the ODS BHR NCI program between August 2021 to November 2023. Eligible participants were under 70 years of age. The patients received comprehensive care and education from a multidisciplinary team, adhering to the program's guidelines. Their postoperative outcomes were monitored on the 1 Result: A total of 206 patients participated in the ODS BHR NCI program during the COVID-19 pandemic in Thailand. The mean age and BMI were 54.21 ± 9.74 years and 24.18 ± 4.02, respectively. The success rate was 99.02 %, with only one case involving a serious complication. Minor complications were reported in 20 cases, including anesthesia-related issues and minor surgical complications. Notably, no patients were diagnosed with COVID-19 following their surgery. Conclusion: Breast cancer surgeries performed under the ODS BHR NCI program achieved a high success rate. The development of pre-, intra-, and post-operative care protocols, alongside comprehensive patient education, has potential to reduce complications and provide an effective model for extending systemic care to a wider range of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.